We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » QRxPharma Gets Second CRL for Painkiller Combo Drug
QRxPharma Gets Second CRL for Painkiller Combo Drug
August 29, 2013
The FDA wants to see more data on QRxPharma’s painkiller Moxduo, the company said Wednesday, following the cancellation of an agency advisory meeting to review the combo drug candidate.